RYTM - Company ID 0001649904
The table below shows RHYTHM PHARMACEUTICALS, INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $62.14M | $52.08M | $135.59M | $106.09M | $47.52M | $161.67M |
| Short-term investments | $278.49M | $363.97M | $155.44M | $208.39M | $250.87M | $157.46M |
| Receivables | $34.19M | $33.03M | $26.12M | $17.82M | $19.31M | $17.60M |
| Inventory | $28.65M | $22.11M | $18.87M | $19.32M | $13.89M | $11.99M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $430.09M |
| $494.80M |
| $360.68M |
| $369.29M |
| $340.34M |
| $357.37M |
| Property, plant & equipment | $1.06M | $237.00K | $297.00K | $462.00K | $801.00K | $973.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $442.32M | $506.87M | $372.73M | $386.69M | $363.57M | $381.85M |
| Accounts payable | $12.30M | $13.63M | $15.98M | $11.91M | $4.89M | $4.54M |
| Total current liabilities | $103.20M | $104.27M | $129.46M | $111.82M | $97.61M | $54.72M |
| Long-term debt | $98.34M | $103.41M | $106.01M | $107.93M | - | - |
| Total liabilities | $204.70M | $211.19M | $239.15M | $223.60M | $210.88M | $202.35M |
| Retained earnings | -$1.41B | -$1.30B | -$1.25B | -$1.20B | -$1.11B | -$1.07B |
| Total equity | $122.91M | $148.82M | -$11.91M | $18.95M | $11.21M | $39.34M |